Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Hairy cell leukemia and sarcoidosis: a case report and review of the literature

Leukemia volume 17, pages 2057–2059 (2003)Cite this article

TO THE EDITOR

Hairy cell leukemia (HCL) is a hematologic neoplasm characterized by infiltration of the bone marrow and spleen by abnormal lymphocytes with prominent hair-like projections. The disorder is rare, constituting roughly 2% of adult leukemias with 600–800 diagnoses per year in the United States. The median age at the time of diagnosis is 52 years with a male to female ratio of 4:1.1 Given current therapy with purine nucleoside analogues, the prognosis of HCL is favorable, with progression-free survival estimated to be 70% at 4 years.2

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

References

  1. Staines A, Cartwright RA . Hairy-cell leukemia: descriptive epidemiology and a case–control study. Br J Haematol 1993; 85: 714.

    Article  CAS  Google Scholar 

  2. Lauria F, Rondelli D, Zinzani PL, Bocchia M, Marotta G, Salvucci M et al. Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5-year survey. Leukemia 1997; 11: 629–632.

    Article  CAS  Google Scholar 

  3. Federico M, Zinzani PL, Frassoldati A, Vinceti M, Mode A, Annino L et al. Risk of second cancer in patients with hairy cell leukemia: long-term follow-up. J Clin Oncol 2002; 20: 638–646.

    Article  Google Scholar 

  4. Carpenter MT, West SG . Polyarteritis nodosa in hairy cell leukemia: treatment with interferon-alpha. J Rheumatol 1994; 21: 1150–1152.

    CAS  PubMed  Google Scholar 

  5. Blanche P, Bachmeyer C, Mikdame M, Dreyfus F, Sicard D . Scleroderma, polymyositis, and hairy cell leukemia. J Rheumatol 1995; 22: 1384–1385.

    CAS  PubMed  Google Scholar 

  6. Berthiot G . Hairy-cell leukaemia and sarcoidosis. Eur J Med 1993; 2: 61.

    CAS  PubMed  Google Scholar 

  7. Myers TJ, Granville NB, Witter BA . Hairy cell leukemia and sarcoid. Cancer 1979; 43: 1777–1781.

    Article  CAS  Google Scholar 

  8. Pettitt AR, Zuzel M, Cawley JC . Hairy-cell leukaemia: biology and management. Br J Haematol 1999; 106: 2–8.

    Article  CAS  Google Scholar 

  9. Newman LS, Rose CS, Maier LA . Sarcoidosis. N Engl J Med 1997; 336: 1224–1234.

    Article  CAS  Google Scholar 

  10. de Totero D, Carbone A, Tazzari PL, Raspadori D, Ventura A, Reato G et al. Expression of the IL2 receptor alpha, beta and gamma chains in hairy cell leukemia. Leuk Lymphoma 1994; 14: 27–32.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oncology, University of California at Los Angeles, Los Angeles, CA, USA

    G Schiller

  2. Department of Pathology, University of California at Los Angeles, Los Angeles, CA, USA

    J Said

  3. Department of Medicine, University of California at Los Angeles, Los Angeles, CA, USA

    S Pal

Authors
  1. G Schiller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J Said
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S Pal
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schiller, G., Said, J. & Pal, S. Hairy cell leukemia and sarcoidosis: a case report and review of the literature. Leukemia 17, 2057–2059 (2003). https://doi.org/10.1038/sj.leu.2403074

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2403074

This article is cited by

Search

Advanced search

Quick links